Literature DB >> 1517932

Recurrent genitourinary chlamydial infections in sexually active female adolescents.

M J Blythe1, B P Katz, B E Batteiger, J A Ganser, R B Jones.   

Abstract

To determine the recurrence rate of chlamydial infections, we initially screened an urban population of 1308 sexually active female adolescents for chlamydial infection at the urethral and endocervical sites; these young women were followed and had additional examinations for infection. Chlamydial infection was documented by tissue culture in 31.1% (407) of them at some time during the study. After appropriate antibiotic treatment, 68.3% (278/407) returned for test-of-cure cultures within 3 months of their initial infection; of those 278, a total of 254 had sterile cultures. These patients were followed to determine the recurrence rate of chlamydial infections. Of these 254 patients, 177 (69.7%) had one or more follow-up visits; 38.4% (68/177) had a recurrent chlamydial infection. The majority of recurrent infections were documented within 9 months of the initial infection. Recurrent infections with the same serovar were frequent, suggesting reinfection by untreated partners or possible relapse of the initial chlamydial infection. This high rate of recurrent infection suggests that female adolescents should be rescreened frequently for genitourinary chlamydial infections.

Entities:  

Mesh:

Year:  1992        PMID: 1517932     DOI: 10.1016/s0022-3476(05)81812-8

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  23 in total

Review 1.  Protective immunity to Chlamydia trachomatis genital infection: evidence from human studies.

Authors:  Byron E Batteiger; Fujie Xu; Robert E Johnson; Michael L Rekart
Journal:  J Infect Dis       Date:  2010-06-15       Impact factor: 5.226

2.  Incidence and reinfection rates of genital chlamydial infection among women aged 16-24 years attending general practice, family planning and genitourinary medicine clinics in England: a prospective cohort study by the Chlamydia Recall Study Advisory Group.

Authors:  D Scott Lamontagne; Kathleen Baster; Lynsey Emmett; Tom Nichols; Sarah Randall; Louise McLean; Paula Meredith; Veerakathy Harindra; Jean M Tobin; Gillian S Underhill; W Graham Hewitt; Jennifer Hopwood; Toni Gleave; Ajit K Ghosh; Harry Mallinson; Alisha R Davies; Gwenda Hughes; Kevin A Fenton
Journal:  Sex Transm Infect       Date:  2006-10-18       Impact factor: 3.519

3.  The impact of community-based sexually transmitted infection screening results on sexual risk behaviors of African American adolescents.

Authors:  Sharon R Sznitman; Michael P Carey; Peter A Vanable; Ralph J DiClemente; Larry K Brown; Robert F Valois; Michael Hennessy; Naomi Farber; Christie Rizzo; Angela Caliendo; Laura F Salazar; Bonita F Stanton; Daniel Romer
Journal:  J Adolesc Health       Date:  2010-03-06       Impact factor: 5.012

4.  Knowledge of sex partner treatment for past bacterial STI and risk of current STI.

Authors:  L M Niccolai; J R Ickovics; K Zeller; T S Kershaw; S Milan; J B Lewis; K A Ethier
Journal:  Sex Transm Infect       Date:  2005-06       Impact factor: 3.519

5.  Efficacy of a motivational behavioral intervention to promote chlamydia and gonorrhea screening in young women: a randomized controlled trial.

Authors:  Mariam R Chacko; Constance M Wiemann; Claudia A Kozinetz; Kirk von Sternberg; Mary M Velasquez; Peggy B Smith; Ralph DiClemente
Journal:  J Adolesc Health       Date:  2009-08-03       Impact factor: 5.012

6.  Effectiveness of patient delivered partner medication for preventing recurrent Chlamydia trachomatis.

Authors:  P Kissinger; R Brown; K Reed; J Salifou; A Drake; T A Farley; D H Martin
Journal:  Sex Transm Infect       Date:  1998-10       Impact factor: 3.519

7.  Detection of Chlamydia trachomatis in an Australian high school student population.

Authors:  J Debattista; P Martin; J Jamieson; K Crane; I Dolton; S Russell-Hall; J DeSilva; R Hargrave; T Robinson; N Ryan; M Mortlock
Journal:  Sex Transm Infect       Date:  2002-06       Impact factor: 3.519

8.  Effects of azithromycin and rifampin on Chlamydia trachomatis infection in vitro.

Authors:  U Dreses-Werringloer; I Padubrin; H Zeidler; L Köhler
Journal:  Antimicrob Agents Chemother       Date:  2001-11       Impact factor: 5.191

9.  Repeated Chlamydia trachomatis genital infections in adolescent women.

Authors:  Byron E Batteiger; Wanzhu Tu; Susan Ofner; Barbara Van Der Pol; Diane R Stothard; Donald P Orr; Barry P Katz; J Dennis Fortenberry
Journal:  J Infect Dis       Date:  2010-01-01       Impact factor: 5.226

Review 10.  Hidden in plain sight: chlamydial gastrointestinal infection and its relevance to persistence in human genital infection.

Authors:  Roger G Rank; Laxmi Yeruva
Journal:  Infect Immun       Date:  2014-01-13       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.